%0 Journal Article %A T., Kimura %A M., Takeuchi %A T., Imai %A S., Tanaka %A K., Kawakami %A Network of Japan, Neonatal Research %D 2017 %T Supplementary Material for: Neurodevelopment at 3 Years in Neonates Born by Vaginal Delivery versus Cesarean Section at <26 Weeks of Gestation: Retrospective Analysis of a Nationwide Registry in Japan %U https://karger.figshare.com/articles/journal_contribution/Supplementary_Material_for_Neurodevelopment_at_3_Years_in_Neonates_Born_by_Vaginal_Delivery_versus_Cesarean_Section_at_26_Weeks_of_Gestation_Retrospective_Analysis_of_a_Nationwide_Registry_in_Japan/5208775 %R 10.6084/m9.figshare.5208775.v1 %2 https://karger.figshare.com/ndownloader/files/8889970 %K Extreme prematurity %K Neurodevelopment %K Cesarean section %K Vaginal delivery %X

Background: A high proportion of extremely preterm (EPT) infants are born by cesarean section (CS). However, whether the mode of delivery is related to long-term neurodevelopment in these infants is unclear. Objectives: This study aimed to determine whether the mode of delivery is associated with mortality and long-term outcomes in EPT infants. Methods: We analyzed data of the Neonatal Research Network in Japan (NRNJ), a population-based, nationwide registry. Inclusion criteria were neonates who were born between 2003 and 2012 with a gestational age <26 weeks. The primary composite outcome was death before 3 years or neurodevelopmental impairment (NDI) at 3 years. Confounder-adjusted odds ratios (OR) were estimated by logistic generalized linear mixed models, which accounted for clustering within hospitals. Results: 2,138 eligible infants (703 by vaginal delivery [VD] and 1,435 by CS) were identified for primary analysis. The composite outcome of death or NDI was not different between both groups (66.7% by VD and 62.7% by CS, p = 0.075). After multivariate analysis adjusting for confounders, we found that CS did not improve the composite outcome of death or NDI (OR = 0.839, 95% confidence interval = 0.816-1.328, p = 0.742). For secondary outcomes, mortality (OR = 0.824, p = 0.150), NDI (OR = 1.237, p = 0.165), and other neurodevelopmental outcomes were not different between the groups. Conclusions: Among neonates born at <26 weeks, CS does not improve mortality and neurodevelopmental outcomes at 3 years in the NRNJ cohort. However, because of several potential biases such as high rates of infants lost to follow-up, further evidence may be required.

%I Karger Publishers